Skip to main content

[vc_row][vc_column][vc_single_image image="62971" img_size="full" alignment="center" css=""][vc_column_text css=""]Two NFCR-supported researchers have recently published in the high-impact publication Nature Communications for their work on liquid biopsies and circulating tumor cells. Drs. Daniel A. Haber of Massachusetts General Hospital Cancer Center and Aditya Bardia of the University of California,...

[vc_row][vc_column][vc_single_image image="24084" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]  In 2017, genetic researchers in the United Kingdom introduced a powerful new mechanical tool in the growing field of genomics, which may guide the way to new cancer treatments. The high-tech genome sequencer, the Illumina NovaSeqTM 6000, was unveiled at...

It’s called “the cloud,” but it is not the fluffy white thingees drifting overhead. It promises to revolutionize cancer care. By, of all things, sharing data. “In cancer, only about 4% of patients go on a clinical trial, but that data is not ever really leveraged....